ARX Practice Manager to Co-chair DIA Digital Signature Conference in May

ARX (Algorithmic Research), a leading provider of digital signature solutions (standard electronic signatures), announced today that Rodd Schlerf, the Life Science Practice Manager for ARX, will be co-chairing the Drug Information Association (DIA) Digital Signature Conference in Arlington, VA, on May 13, 2008. The event, “Digital Signatures: Practical Strategies for Life Science Organizations”, will focus on recent developments that remove obstacles like cost and complexity from the deployments of digital signatures. Thought leaders from biopharmaceutical companies, CROs, and technology organizations will discuss considerations and strategies that make the deployment of digital signature technologies quick, affordable, and practical for organizations of every size.

“This event focuses on the rapidly growing use of digital signatures across all applications in a life science organization,” said program Co-Chair Rodd Schlerf.

There are many forms of electronic signatures that can comply with FDA 21 CFR Part 11. However, only standards-based digital signatures enable the benefits of digital signatures to extend beyond pure compliance requirements and facilitate accelerated decision making, expedited approval processes, operational cost reductions, and more efficient and paperless operations both inside an organization and externally in B2B or electronic submission applications.

During the DIA event, Mr. Schlerf and other industry thought leaders from biopharmaceutical companies, CROs, and technology providers will discuss strategies that facilitate the adoption of digital signatures for organizations of every size. Moreover, case studies will be provided from organizations that have successfully implemented digital signature applications for processes including internal quality and clinical operations, large web-based business-to-business portals, and cross-organizational workflows.